Outcome of renal transplantation in patients with type 2 diabetic nephropathy: A single-center experience

Hiroshi Noguchi, H. Kitada, Keizo Kaku, Kei Kurihara, S. Kawanami, akihiro tsuchimoto, Kosuke Masutani, Udai Nakamura, M. Tanaka

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background Renal transplantation has been established as a treatment for end-stage renal disease (ESRD) due to diabetic nephropathy. However, few studies have focused on the outcome after renal transplantation in patients with ESRD and type 2 diabetic nephropathy. To investigate the effect of renal transplantation on ESRD with type 2 diabetic nephropathy, we retrospectively analyzed patients who received renal transplantation at our facility. This study aimed to compare the outcome of renal transplantation for type 2 diabetic nephropathy with that for nondiabetic nephropathy. Methods We studied 290 adult patients, including 65 with type 2 diabetic nephropathy (DM group) and 225 with nondiabetic nephropathy (NDM group), who underwent living-donor renal transplantation at our facility from February 2008 to March 2013. We compared the 2 groups retrospectively. Results In the DM and NDM groups, the 5-year patient survival rates were 96.6% and 98.7%, and the 5-year graft survival rates were 96.8% and 98.0%, respectively, with no significant differences between the groups. There were no significant differences in the rates of surgical complications, rejection, and infection. The cumulative incidence of postoperative cardiovascular events was higher in the DM group than in the NDM group (8.5% vs 0.49% at 5 years; P =.002). Conclusions Patient and graft survival rates after renal transplantation for type 2 diabetic nephropathy are not inferior to those for recipients without diabetic nephropathy. Considering the poor prognosis of patients with diabetic nephropathy on dialysis, renal transplantation can provide significant benefits for these patients.

Original languageEnglish
Pages (from-to)608-611
Number of pages4
JournalTransplantation Proceedings
Volume47
Issue number3
DOIs
Publication statusPublished - Apr 1 2015

Fingerprint

Diabetic Nephropathies
Kidney Transplantation
Chronic Kidney Failure
Survival Rate
Graft Survival
Living Donors
Dialysis
Incidence
Infection

All Science Journal Classification (ASJC) codes

  • Surgery
  • Transplantation

Cite this

Outcome of renal transplantation in patients with type 2 diabetic nephropathy : A single-center experience. / Noguchi, Hiroshi; Kitada, H.; Kaku, Keizo; Kurihara, Kei; Kawanami, S.; tsuchimoto, akihiro; Masutani, Kosuke; Nakamura, Udai; Tanaka, M.

In: Transplantation Proceedings, Vol. 47, No. 3, 01.04.2015, p. 608-611.

Research output: Contribution to journalArticle

@article{da7c8cd8720c48dabfc4ebacb1eb76c4,
title = "Outcome of renal transplantation in patients with type 2 diabetic nephropathy: A single-center experience",
abstract = "Background Renal transplantation has been established as a treatment for end-stage renal disease (ESRD) due to diabetic nephropathy. However, few studies have focused on the outcome after renal transplantation in patients with ESRD and type 2 diabetic nephropathy. To investigate the effect of renal transplantation on ESRD with type 2 diabetic nephropathy, we retrospectively analyzed patients who received renal transplantation at our facility. This study aimed to compare the outcome of renal transplantation for type 2 diabetic nephropathy with that for nondiabetic nephropathy. Methods We studied 290 adult patients, including 65 with type 2 diabetic nephropathy (DM group) and 225 with nondiabetic nephropathy (NDM group), who underwent living-donor renal transplantation at our facility from February 2008 to March 2013. We compared the 2 groups retrospectively. Results In the DM and NDM groups, the 5-year patient survival rates were 96.6{\%} and 98.7{\%}, and the 5-year graft survival rates were 96.8{\%} and 98.0{\%}, respectively, with no significant differences between the groups. There were no significant differences in the rates of surgical complications, rejection, and infection. The cumulative incidence of postoperative cardiovascular events was higher in the DM group than in the NDM group (8.5{\%} vs 0.49{\%} at 5 years; P =.002). Conclusions Patient and graft survival rates after renal transplantation for type 2 diabetic nephropathy are not inferior to those for recipients without diabetic nephropathy. Considering the poor prognosis of patients with diabetic nephropathy on dialysis, renal transplantation can provide significant benefits for these patients.",
author = "Hiroshi Noguchi and H. Kitada and Keizo Kaku and Kei Kurihara and S. Kawanami and akihiro tsuchimoto and Kosuke Masutani and Udai Nakamura and M. Tanaka",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.transproceed.2014.12.047",
language = "English",
volume = "47",
pages = "608--611",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Outcome of renal transplantation in patients with type 2 diabetic nephropathy

T2 - A single-center experience

AU - Noguchi, Hiroshi

AU - Kitada, H.

AU - Kaku, Keizo

AU - Kurihara, Kei

AU - Kawanami, S.

AU - tsuchimoto, akihiro

AU - Masutani, Kosuke

AU - Nakamura, Udai

AU - Tanaka, M.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Background Renal transplantation has been established as a treatment for end-stage renal disease (ESRD) due to diabetic nephropathy. However, few studies have focused on the outcome after renal transplantation in patients with ESRD and type 2 diabetic nephropathy. To investigate the effect of renal transplantation on ESRD with type 2 diabetic nephropathy, we retrospectively analyzed patients who received renal transplantation at our facility. This study aimed to compare the outcome of renal transplantation for type 2 diabetic nephropathy with that for nondiabetic nephropathy. Methods We studied 290 adult patients, including 65 with type 2 diabetic nephropathy (DM group) and 225 with nondiabetic nephropathy (NDM group), who underwent living-donor renal transplantation at our facility from February 2008 to March 2013. We compared the 2 groups retrospectively. Results In the DM and NDM groups, the 5-year patient survival rates were 96.6% and 98.7%, and the 5-year graft survival rates were 96.8% and 98.0%, respectively, with no significant differences between the groups. There were no significant differences in the rates of surgical complications, rejection, and infection. The cumulative incidence of postoperative cardiovascular events was higher in the DM group than in the NDM group (8.5% vs 0.49% at 5 years; P =.002). Conclusions Patient and graft survival rates after renal transplantation for type 2 diabetic nephropathy are not inferior to those for recipients without diabetic nephropathy. Considering the poor prognosis of patients with diabetic nephropathy on dialysis, renal transplantation can provide significant benefits for these patients.

AB - Background Renal transplantation has been established as a treatment for end-stage renal disease (ESRD) due to diabetic nephropathy. However, few studies have focused on the outcome after renal transplantation in patients with ESRD and type 2 diabetic nephropathy. To investigate the effect of renal transplantation on ESRD with type 2 diabetic nephropathy, we retrospectively analyzed patients who received renal transplantation at our facility. This study aimed to compare the outcome of renal transplantation for type 2 diabetic nephropathy with that for nondiabetic nephropathy. Methods We studied 290 adult patients, including 65 with type 2 diabetic nephropathy (DM group) and 225 with nondiabetic nephropathy (NDM group), who underwent living-donor renal transplantation at our facility from February 2008 to March 2013. We compared the 2 groups retrospectively. Results In the DM and NDM groups, the 5-year patient survival rates were 96.6% and 98.7%, and the 5-year graft survival rates were 96.8% and 98.0%, respectively, with no significant differences between the groups. There were no significant differences in the rates of surgical complications, rejection, and infection. The cumulative incidence of postoperative cardiovascular events was higher in the DM group than in the NDM group (8.5% vs 0.49% at 5 years; P =.002). Conclusions Patient and graft survival rates after renal transplantation for type 2 diabetic nephropathy are not inferior to those for recipients without diabetic nephropathy. Considering the poor prognosis of patients with diabetic nephropathy on dialysis, renal transplantation can provide significant benefits for these patients.

UR - http://www.scopus.com/inward/record.url?scp=84928353359&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928353359&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2014.12.047

DO - 10.1016/j.transproceed.2014.12.047

M3 - Article

C2 - 25817610

AN - SCOPUS:84928353359

VL - 47

SP - 608

EP - 611

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 3

ER -